Filana Therapeutics, Inc. Public Float
Filana Therapeutics, Inc. (FLNA) had Public Float of $87.00 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $87.00M.
- 2024-06-28: Entity Public Float $558.00M.
- 2023-06-30: Entity Public Float $967.00M.
- 2022-06-30: Entity Public Float $1.10B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $87.00M 10-K · filed 2026-03-12 |
| 2024-06-28 | $558.00M 10-K · filed 2025-03-03 |
| 2023-06-30 | $967.00M 10-K · filed 2024-02-28 |
| 2022-06-30 | $1.10B 10-K · filed 2023-02-28 |
| 2021-06-30 | $3.20B 10-K · filed 2022-03-01 |
| 2020-06-30 | $71.15M 10-K · filed 2021-03-23 |
| 2019-06-28 | $19.38M 10-K · filed 2020-03-26 |
| 2018-06-30 | $11.96M 10-K · filed 2019-03-29 |
| 2017-06-30 | $22.84M 10-K · filed 2018-02-06 |
| 2016-06-30 | $84.61M 10-K · filed 2017-03-07 |
| 2015-06-30 | $66.21M 10-K · filed 2016-03-03 |
| 2014-06-30 | $219.56M 10-K · filed 2015-02-18 |
| 2013-06-30 | $82.91M 10-K · filed 2014-02-05 |
| 2012-06-30 | $179.72M 10-K · filed 2013-02-08 |
| 2011-06-30 | $144.13M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |